NCT03576131 · OUTCOME
Volume of Distribution (Vss) at Steady State of Hx-DR5-01 and Hx-DR5-05
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors · Source last updated 2023-08-01
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- GEOMETRIC_MEAN
- Unit
- mL
- Interval / dispersion
- Geometric Coefficient of Variation
- Time frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
What was measured
The Vss of Hx-DR5-01 and Hx-DR5-05 are reported.
Analysis population: PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
Groups in this outcome
Biweekly Regimen (GEN1029 0.1 mg/kg)
Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
Biweekly Regimen (GEN1029 0.2 mg/kg)
Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 0.3 mg/kg)
Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 1.0 mg/kg)
Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 2.0 mg/kg)
Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
Biweekly Regimen (GEN1029 3.0 mg/kg)
Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Reported measurements
Vss Hx-DR5-01 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 5366.8 | 35.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4788.6 | 5.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3666.8 | 49.4 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 3834.6 | 34.3 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4885.9 | 18.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 4127.3 | 19.2 | Not reported | Not reported | Not reported |
|---|
Vss Hx-DR5-01 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 4720.0 | 34.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4287.5 | 10.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 5283.0 | 62.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 3998.1 | 24.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4185.8 | 17.3 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 3427.5 | 25.1 | Not reported | Not reported | Not reported |
|---|
Vss Hx-DR5-01 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 4622.7 | 31.1 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4531.9 | 6.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3243.6 | 14.3 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 4075.3 | 26.2 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4227.1 | 8.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 4118.5 | NA | Not reported | Not reported | Geometric coefficient of variation was not derived as only one participant was evaluated for this arm. |
|---|
Vss Hx-DR5-05 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 8 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 4722.7 | 55.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 5242.9 | 15.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3942.4 | 63.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 3611.0 | 26.5 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4291.6 | 9.8 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 4142.9 | 21.0 | Not reported | Not reported | Not reported |
|---|
Vss Hx-DR5-05 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 7 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 4899.3 | 22.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 4701.6 | 15.0 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 5177.9 | 100.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 4054.4 | 16.4 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 4334.9 | 14.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 3187.8 | 41.0 | Not reported | Not reported | Not reported |
|---|
Vss Hx-DR5-05 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 5 |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 3 |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 2 |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in mL · Interval/dispersion: Geometric Coefficient of Variation| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Biweekly Regimen (GEN1029 0.1 mg/kg) | 4812.5 | 31.9 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.2 mg/kg) | 5077.6 | 24.1 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 0.3 mg/kg) | 3577.1 | 15.7 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 1.0 mg/kg) | 4951.2 | 42.4 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 2.0 mg/kg) | 5130.8 | 5.6 | Not reported | Not reported | Not reported |
|---|
| Biweekly Regimen (GEN1029 3.0 mg/kg) | 4173.9 | NA | Not reported | Not reported | Geometric coefficient of variation was not derived as only one participant was evaluated for this arm. |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 35.0
- value
- 5366.8
- group Id
- OG001
- spread
- 5.0
- value
- 4788.6
- group Id
- OG002
- spread
- 49.4
- value
- 3666.8
- group Id
- OG003
- spread
- 34.3
- value
- 3834.6
- group Id
- OG004
- spread
- 18.8
- value
- 4885.9
- group Id
- OG005
- spread
- 19.2
- value
- 4127.3
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- Vss Hx-DR5-01 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 34.9
- value
- 4720.0
- group Id
- OG001
- spread
- 10.5
- value
- 4287.5
- group Id
- OG002
- spread
- 62.0
- value
- 5283.0
- group Id
- OG003
- spread
- 24.0
- value
- 3998.1
- group Id
- OG004
- spread
- 17.3
- value
- 4185.8
- group Id
- OG005
- spread
- 25.1
- value
- 3427.5
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 7
- group Id
- OG004
- value
- 4
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- Vss Hx-DR5-01 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 31.1
- value
- 4622.7
- group Id
- OG001
- spread
- 6.7
- value
- 4531.9
- group Id
- OG002
- spread
- 14.3
- value
- 3243.6
- group Id
- OG003
- spread
- 26.2
- value
- 4075.3
- group Id
- OG004
- spread
- 8.7
- value
- 4227.1
- comment
- Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
- group Id
- OG005
- spread
- NA
- value
- 4118.5
- denoms
- counts
- group Id
- OG000
- value
- 6
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- Vss Hx-DR5-01 Cycle 3 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 55.6
- value
- 4722.7
- group Id
- OG001
- spread
- 15.8
- value
- 5242.9
- group Id
- OG002
- spread
- 63.6
- value
- 3942.4
- group Id
- OG003
- spread
- 26.5
- value
- 3611.0
- group Id
- OG004
- spread
- 9.8
- value
- 4291.6
- group Id
- OG005
- spread
- 21.0
- value
- 4142.9
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 6
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- Vss Hx-DR5-05 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 22.7
- value
- 4899.3
- group Id
- OG001
- spread
- 15.0
- value
- 4701.6
- group Id
- OG002
- spread
- 100.6
- value
- 5177.9
- group Id
- OG003
- spread
- 16.4
- value
- 4054.4
- group Id
- OG004
- spread
- 14.9
- value
- 4334.9
- group Id
- OG005
- spread
- 41.0
- value
- 3187.8
- denoms
- counts
- group Id
- OG000
- value
- 7
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- Vss Hx-DR5-05 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- spread
- 31.9
- value
- 4812.5
- group Id
- OG001
- spread
- 24.1
- value
- 5077.6
- group Id
- OG002
- spread
- 15.7
- value
- 3577.1
- group Id
- OG003
- spread
- 42.4
- value
- 4951.2
- group Id
- OG004
- spread
- 5.6
- value
- 5130.8
- comment
- Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.
- group Id
- OG005
- spread
- NA
- value
- 4173.9
- denoms
- counts
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 2
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- Vss Hx-DR5-05 Cycle 3 Day 1
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 7
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- description
- The Vss of Hx-DR5-01 and Hx-DR5-05 are reported.
- dispersion Type
- Geometric Coefficient of Variation
- groups
- description
- Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
- id
- OG000
- title
- Biweekly Regimen (GEN1029 0.1 mg/kg)
- description
- Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG001
- title
- Biweekly Regimen (GEN1029 0.2 mg/kg)
- description
- Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG002
- title
- Biweekly Regimen (GEN1029 0.3 mg/kg)
- description
- Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG003
- title
- Biweekly Regimen (GEN1029 1.0 mg/kg)
- description
- Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG004
- title
- Biweekly Regimen (GEN1029 2.0 mg/kg)
- description
- Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG005
- title
- Biweekly Regimen (GEN1029 3.0 mg/kg)
- param Type
- GEOMETRIC_MEAN
- population Description
- PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
- reporting Status
- POSTED
- time Frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
- title
- Volume of Distribution (Vss) at Steady State of Hx-DR5-01 and Hx-DR5-05
- type
- SECONDARY
- unit Of Measure
- mL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice